Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Cappel

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2020
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression modelAlexander M M Eggermont, Domenico Bellomo, Suzette M Arias-Mejias, et al.
JCO Precision Oncology|May 15, 2020
Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous MelanomaDomenico Bellomo, Suzette M Arias-Mejias, Chandru Ramana, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2020
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression modelAlexander M M Eggermont, Domenico Bellomo, Suzette M Arias-Mejias, et al.
JCO Precision Oncology|May 15, 2020
Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous MelanomaDomenico Bellomo, Suzette M Arias-Mejias, Chandru Ramana, et al.
Pageof 4